Isolation and characterization of benazepril unknown impurity by chromatographic and spectroscopic methods

The presence of unknown impurity of the order of 0.2% was identified in benazepril using liquid chromatographic technique employing binary gradient system comprising acetic acid and ammonia in water and acetonitrile as the mobile phase. LCMS data corresponds to hydroxylated benazepril (OHB) derivative possessing the molecular formula C(24)H(28)N(2)O(6). This impurity was isolated using isocratic system containing ammonium acetate and acetonitrile and the product was characterized using FT-IR, (1)H and (13)C NMR and mass spectroscopy to ascertain the structure of the impurity. The spectroscopic analysis revealed the presence of hydroxyl function on C(17) carbon atom of benazepril molecule. The plausible mechanism for the formation of OHB species is proposed.

Formal synthesis of the ACE inhibitor benazepril x HCl via an asymmetric aza-Michael reaction

A formal enantioselective synthesis of benazepril.HCl (4), an anti- hypertensive drug, is reported. Our synthesis employed an asymmetric aza-Michael addition of L-homophenylalanine ethyl ester (LHPE, 1) to 4-(2-nitrophenyl)-4-oxo- but-2-enoic acid methyl ester (6) as the key step to prepare (2S,3'S)-2-(2-oxo-2,3,4,5- tetrahydro-1H-benzo[b]azepin-3-ylamino)-4-phenylbutyric acid ethyl ester (8), which is the key intermediate leading to benazepril x HCl (4).

Efficient asymmetric synthesis of the vasopeptidase inhibitor BMS-189921

[reaction: see text] An efficient asymmetric synthesis of the vasopeptidase inhibitor BMS-189921 was accomplished. Two short enantioselective syntheses of the common key intermediate (S)-alpha-aminoazepinone 6b were developed. Olefin 3 was converted to 6b via asymmetric hydrogenation. Alternatively, enyne 12 was converted to racemic alpha-aminoazepinone 15b, which was transformed to 6b by a practical dynamic resolution.